Diagnosis of paroxysmal nocturnal haemoglobinuria by phenotypLc analysis of erythrocytes using two‐colour flow cytometry with monoclonal antibodies to DAF and CD59/MACIF
- 1 October 1993
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 85 (2) , 378-386
- https://doi.org/10.1111/j.1365-2141.1993.tb03182.x
Abstract
Summary We investigated the relationship between the complement lysis sensitivity test and two‐colour flow cyto‐metric analysis using monoclonal antibodies to decay accelerating factor (DAF) and CD59/membrane attack complex inhibitory factor (MACIF) in patients with paroxysmal nocturnal haemoglobinuria (PNH) and other haematological diseases.Flow cytometry showed that all 59 PNH patients had two or three erythrocyte populations, while all 74 patients with other haematological diseases and all 31 healthy volunteers had a single erythrocyte population. We compared the percentage of PNH III erythrocytes in the lysis test with the percentage of negative cells shown by flow cytometry in 52 PNH patients, and found a significant correlation (r=0–960, P<0.001). However, in 13 patients the erythrocyte pheno‐types did not correspond in both tests. This was generally related to difficulty of detecting PNH II erythrocytes in the lysis test.In the PNH patients the ranges of mean fluorescence intensity for the negative, intermediate and positive erythrocyte populations were respectively 1.1–2.5. 2.2–29, and 61–600 for CD59IMACIF positivity and 1.9–7.2, 3.6–22, and 31–350 for DAF positivity. In contrast, the mean intensities in healthy volunteers ranged from 190 to 720 for CD59/ MACIF and from 150 to 350 for DAF.These findings suggest that PNH can be diagnosed and phenotypic analysis of PNH erythrocytes can be performed by respectively assessing the fluorescence profiles and mean fluorescence intensities of both proteins using flow cytometry. Flow cytometry may provide a superior diagnostic method to the traditional tests for PNH.Keywords
This publication has 29 references indexed in Scilit:
- The erythrocytes in paroxysmal nocturnal haemoglobinuria of intermediate sensitivity to complement lysisBritish Journal of Haematology, 1991
- Fc III receptors (FcRIII) on granulocytes: A specific and sensitive diagnostic test for paroxysmal nocturnal hemoglobinuria (PNH)European Journal of Haematology, 1991
- Relationship between the proportion of paroxysmal nocturnal hemoglobinuria (PNH) III‐erythrocytes and the frequency of exacerbated hemoglobinuria in PNHEuropean Journal of Haematology, 1991
- Heterogenous expression of decay accelerating factor and CD59/membrane attack complex inhibition factor on paroxysmal nocturnal haemoglobinuria (PNH) erythrocytesBritish Journal of Haematology, 1991
- Estimation of PI‐bound proteins on blood cells from PNH patients by quantitative flow cytometryBritish Journal of Haematology, 1990
- Relationship between the membrane inhibitor of reactive lysis and the erythrocyte phenotypes of paroxysmal nocturnal hemoglobinuria.Journal of Clinical Investigation, 1989
- CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells.The Journal of Experimental Medicine, 1989
- Relationship between decay accelerating factor deficiency, diminished acetylcholinesterase activity, and defective terminal complement pathway restriction in paroxysmal nocturnal hemoglobinuria erythrocytes.Journal of Clinical Investigation, 1987
- Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. I. The sensitivity of PNH red cells to lysis by complement and specific antibody.Journal of Clinical Investigation, 1966
- STUDIES ON DESTRUCTION OF RED BLOOD CELLS. II. CHRONIC HEMOLYTIC ANEMIA WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: CERTAIN IMMUNOLOGICAL ASPECTS OF THE HEMOLYTIC MECHANISM WITH SPECIAL REFERENCE TO SERUM COMPLEMENT 1Journal of Clinical Investigation, 1939